retatrutide type 2 diabetes trial results 2024 phase 2 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with diabetes: a randomised, Lilly's triple agonist, retatrutide, demonstrated

If youre feeling cold on semaglutide, its likely due to the weight loss youve achieved in concert with the medicinebut the drug itself plays a role, too

They may technically include real GLP-1 medication, but we have no idea about whether its compounded and therefore poses safety risks. Dr South said GPs can push against this by directing their patients to trusted, quality information, including from the government and not-for-profit health organisations

Wondr Health, Jan

It sensitizes your gut to satiety signals, making every bite more satisfying

It is important to remember that retatrutide is an investigational drug and is currently in phase 3 clinical trials

Where can researchers buy retatrutide in Canada